The OLAM study investigates the safety and feasibility of lisdexamphetamine (a stimulant medication) to assist people in methamphetamine withdrawal.
The results of our study showed Lisdexamphetamine to be a safe and feasible pharmacotherapy for people experiencing methamphetamine withdrawal.
The results are promising but more research (a randomized control trial) is required.